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satisfaction of inpatient and outpatient setting are inﬂuenced by
the different variables. The disease cure is enough to interpreter
the whole satisfaction in inpatient. But in outpatient setting,
other than the variable of symptoms relieved, there are more
variables inﬂuenced the patient satisfaction. However, the other
medical process such as waiting time for several stages, patient
privacy, patient right, informed consent and so on did not inﬂu-
ence patient satisfaction.
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OBJECTIVES: The PROLabels database (www.mapi-prolabels.
org) was developed to provide easy access to Patient-Reported
Outcomes (PROs) included in approved labeling of products in
Europe and the USA. Two years after its launch, the coverage of
FDA labels has been extended to give a more comprehensive
image of the current use of PROs in clinical studies. METHODS:
In 2006, the database opened with drugs approved in Europe
through the centralized procedure established by the EMEA in
January 1995 and with New Molecular Entities (NME)
approved in the USA since January 1998. The extension project
focused on other chemical types approved by FDA (e.g. New
dosage form, New combination, etc.) and on NME approved
before 1998. Once a PRO claim was identiﬁed in a label, the drug
was added in PROLabels and the following information was
retrieved: the PRO claim, description of clinical studies support-
ing the claim, description of PRO endpoints and measures used,
pharmacological action of products and information source.
RESULTS: Updated ﬁgures resulting from this major extension
of PROLabels will be presented. These new ﬁgures will include
the number of drug products present in the database with the
FDA/EMEA distribution, the most represented therapeutic areas
(currently nervous system diseases: 27.8%, immune system dis-
eases: 20.6%, respiratory tract diseases: 16.5%, pathological
conditions, signs and symptoms: 14.9%, and mental disorders:
14.6%), and the most frequently measured PROs (currently
Signs and Symptoms followed by Health-Related Quality of Life
(HRQL)). Finally, any change in the rate of PRO data found
overall in FDA approvals will be checked. CONCLUSIONS:
This extension of the FDA coverage of the PROLabels database
allows a clearer picture of the use of PROs to assess patients’
treatment beneﬁt to be drawn. In addition, it facilitates the
examination of the discrepancies between the US and European
regulatory agencies.
PMC49
COMPARISON OF HEALTH LOCUS OF CONTROL BETWEEN
PHYSICIANS ANDTHE GENERAL PUBLIC: MULTI-GROUP
STRUCTURAL EQUATION MODELING
Tokuda Y1, Ohde S2,Takahashi O3, Omata F1, Jacobs J1, Hinohara S2,
Fukui T3
1St. Luke’s Life Science Institute, Chuo City,Tokyo, Japan, 2St. Luke’s
Life Science Institute, Chuo,Tokyo, Japan, 3St. Luke’s International
Hospital, Chuo,Tokyo, Japan
OBJECTIVES: Health locus of control (HLC) is associated with
health-related behaviors such as adherence and participation in
health screening. However, HLC among physicians may be dif-
ferent from that among the general public. It is important to
understand the potential gap in HLC between physicians and the
general public. The aim of the study included two steps: 1) to
evaluate item bias of the HLC scale between physicians and the
general public, and 2) to characterize HLC among physicians
compared to the general public. METHODS: Data for the
general public were obtained from the health diary study that
involved a random sample from a nationally representative
group of households in Japan. Physicians’ data were collected
from a web-based survey of Japanese physicians. Multi-group
structural equation modeling was used for examining item bias in
the Japanese version of the HLC scale (HLCS-J) between the two
groups. Differential item functioning (DIF), including uniform
and non-uniform types, were used for measuring item bias.
Dimensions with no uniform and non-uniform DIFs were then
compared using multiple linear regressions. RESULTS: Data on
the HLCS-J of 2194 people from the general public and 895
physicians were available. Uniform DIF was recognized for the
dimensions of internal, professional control and control by spiri-
tual powers. Chance and family control dimensions had no DIF.
Mean score for chance control (17.2) among physicians was
greater than that (14.9) among the general public (adjusted
p < 0.001), while mean score for family control (21.7) among
physicians was lower than that (22.1) among the general public
(adjusted p < 0.001). CONCLUSIONS: Our psychometric evalu-
ation of the HLCS-J indicates item bias in the dimensions of
internal, professional control and control by spiritual powers.
Physicians believe that chance has a greater impact but family
control has a lesser impact on health than do members of the
general public.
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OBJECTIVES: The VAS is a common response scale in PRO
questionnaires, which are used in multinational studies from
which data is pooled. This study was designed to evaluate the
suitability of VAS for use in different international settings,
speciﬁcally to evaluate the cognitive processes and challenges
occurring when respondents from a range of countries/cultures
complete VAS. METHODS: Adults were recruited from: UK;
Mexico; Spain; Malaysia; India; South Africa, with approxi-
mately 50:50 males/females and higher/lower education split.
Each completed four VAS followed by a cognitive debrieﬁng
interview, once before and once after receiving standardized
instructions. RESULTS: Thirty-seven lay persons were inter-
viewed across 6 countries, mean age was 46  19; 51.4% were
male. Several respondents commented on the unfamiliar style of
the VAS. Some reported the anchors as inappropriate/ambiguous,
impeding scale completion, or that anchor wording caused them
to avoid scale extremities. Respondents noted the lack of inter-
mediate markers on the VAS, therefore having to rely on ‘guess-
work’: most used quantitative rather than qualitative strategies
when deciding where to place their mark. Some had concerns
that ‘guesswork’ led to inaccurate responses. British and Spanish
respondents used principally quantitative methods whereas Zulu
speakers relied more on qualitative techniques. Respondents
from Malaysia, South Africa and India were more inclined to
report challenges; Zulu and Tamil speakers completed the VAS in
the least conventional way. CONCLUSIONS: The study provides
substantial evidence that the use of VAS in different international
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settings will result in data which has been inﬂuenced by differ-
ences in interpretation of the scale, providing support for the
FDA’s perspective that VAS can provide a ‘false sense of preci-
sion’. This has implications for international clinical trials in
which data pooling is required. This study allowed for a critical
appraisal of the VAS response format which will assist in the
collection of more valid data in multinational studies.
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OBJECTIVE: In contrast to effectiveness of health care interven-
tions, health states preferences might not be transferable between
countries. A frequently used instrument to measure health-
related quality of life is the EQ-5D, which has been developed to
compare preferences across countries. Although the impact of
using any of the ﬁfteen national EQ-5D value sets on utility
estimates is known, the impact on the incremental utility is
unknown so far. METHODS: First, the relative inﬂuence of the
EQ-5D domains on the utility estimate was assessed for each of
the ﬁfteen currently existing value sets. Second, two health states
(21232 and 33321) were selected for further analyses. With the
help of the two hypothetical health states we determined the
inﬂuence of one or two point deteriorations of the health states.
Based on this, the ﬁfteen value sets were used to calculate incre-
mental utility scores. RESULTS: Differences can be perceived
between the value sets and between the valuation methods in the
preferences for the domains of the EQ-5D. The utility scores of
health states show that the differences between the value sets are
substantial. Next to that, the dissimilarities between the incre-
ments of the deteriorations of the health sets are large, indepen-
dent of which valuation method is used. CONCLUSION: All
results indicate that the differences between the value sets are
considerable and should not be ignored. The magnitudes of the
coefﬁcients of the domains vary in a great extent, which causes
dissimilarities when calculating the incremental utilities. As a
consequence it can be concluded that the utility scores are not
transferable across countries.
CONCEPTUAL PAPERS & RESEARCH ON
METHODS—Study Design
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OBJECTIVES: No measures of health-related absenteeism and
presenteeism have been validated for use in French-speaking
Canada. It is important to understand how illness affects an
employee’s productivity and therefore an organization’s proﬁt-
ability; when ill, an employee may take a sick day (absenteeism)
or attend work despite the illness and experience a loss of work
efﬁciency (presenteeism). The WPAI-GH, a leading measure of
these work productivity indicators, has not yet been tested in
French Canada to test for both clarity of translation and item
comprehension. Before using a French translation of an available
English-language questionnaire, the linguistic validity of this new
version must be established to ensure its conceptual equivalence
to the original as well as its cultural appropriateness. The objec-
tive of this study was to evaluate the linguistic validity of the
Canadian French version of the Work Productivity and Activity
Impairment questionnaire, General Health Version (WPAI:GH).
METHODS: A Canadian French translation of the US English
WPAI:GH was created through a reiterative process of creating
harmonized forward and back translations by independent
translators. French-speaking subjects residing in Canada self-
administered the WPAI:GH and were subsequently debriefed by
a bilingual (French-English) interviewer. RESULTS: Thirty
French-Canadian subjects were interviewed, all of whom were
currently employed at the time of the interview. The group was
stratiﬁed by educational level, including an equal number of
participants both with and without a high school degree. The
WPAI:GH item comprehension rate was 97.2%; no response
revisions were offered by any of the subjects. Responses to hypo-
thetical scenarios indicated that the French for Canada language
version adequately differentiates sick time taken for health and
non-health reasons and between absenteeism and presenteeism.
CONCLUSIONS: Linguistic validity of the French for Canada
translation of the WPAI:GH was established among a diverse
French Canadian population, including those with minimal
education.
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OBJECTIVES: In economic evaluation it is often assumed that
utility is a linear function of lifetime. The aim of this study was
ﬁrst to test the assumption of linearity, for short increases in
longevity, and second to test whether there exists a minimum
threshold below which life extensions are not utility bearing.
METHODS: A representative sample of the population
(n = 2,400) was asked to imagine that they had a limited remain-
ing lifetime (1 year or 10 years) and were offered a treatment that
would increase lifetime by 1, 2, 4, 8, 16, 32 weeks (1 year
perspective) or 2, 3, 8, 12, 32 or 52 weeks (10 years perspective).
In each perspective, the price of treatment was constant per week
life extension (i.e. constant proportions of acceptance across
formats would indicate a linear utility function). Additionally,
respondents were asked about their maximum willingness-to-pay
(WTP) for the life extension. RESULTS: The proportions that
accepted the treatment offer to the given price increased with
increasing extensions (1 year: 48%, 54%, 55%, 59%, 59%,
61%; 10 years: 55%, 60%, 62%, 66%, 65%, 76%) indicating a
convex utility function. In maximum WTP, the groups of respon-
dents with increasing and diminishing marginal utility functions
were of similar sizes. The proportions with zero WTP for the
treatment declined from 34% for one week life extension to 14%
for 52 weeks. The results were conﬁrmed in various econometric
models. CONCLUSIONS: While most health care programmes
offer life extensions of less than one year, considerable propor-
tions of the population may be unwilling to pay anything for
such gains. For life extensions up to one year, most of the results
indicate an increasing marginal utility function for lifetime.
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OBJECTIVES: Systematic reviews have become increasingly
important in recent years, particularly to inform the inclusion of
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